MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease

    E. de Pablo-Fernandez, V. Passananti, N. Zárate-López, A. Emmanuel, T. Warner (London, United Kingdom)

    Objective: To perform a comprehensive assessment of constipation in Parkinson’s disease (PD) using various complementary diagnostic techniques to elucidate its pathophysiology and improve its symptomatic…
  • 2019 International Congress

    Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

    M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)

    Objective: To describe and compare characteristics of African American (AA) and White Parkinson’s Disease (PD) patients seen in a large clinic practice at the University…
  • 2019 International Congress

    Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

    E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: We aimed to investigate executive functions and languages abilities in PSP patients and in Progressive Supranuclear Palsy (PSP) subgroups [PSP-Richardson’s Syndrome (PSP-RS) and PSP-non-RS]…
  • 2019 International Congress

    Do non-motor fluctuations temporarily match ON/OFF motor condition?

    E. Del Prete, E. Schmitt, S. Meoni, V. Fraix, A. Castrioto, P. Pelissier, R. Ceravolo, E. Moro (Grenoble, France)

    Objective: The aim of this study was to explore the relation between non-motor neuropsychological fluctuations, identified with the Neuropsychiatric Fluctuation Scale (NFS), and motor fluctuations…
  • 2019 International Congress

    Continuous dopaminergic treatment with levodopa/carbidopa intestinal gel in multiple system atrophy: report of three patients

    S. Delalic, S. Ibrulj, N. Zupancic, D. Flisar, M. Trost, Z. Pirtosek, M. Kojovic (Ljubljana, Slovenia)

    Objective: To evaluate the effect of continuous dopaminergic treatment with levodopa/carbidopa intestinal gel (LCID) on motor and non-motor symptoms in multiple system atrophy (MSA) patients.…
  • 2019 International Congress

    Factors Affecting Mortality in Late Stage Parkinson’s Disease

    S. Dempsey, L. Mcdonald, I. Sayers, WK. Gray, A. Hand, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the effect of dysphagia and hospital admissions on mortality in late stage Parkinson's disease. Background: Parkinson’s disease (PD) is a neurodegenerative condition…
  • 2019 International Congress

    Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India

    S. Desai (Anand, India)

    Objective: We intended to assess presence of cervical and lumbosacral spondylosis our patients with parkinsonism. Background: We have observed that patients with Parkinson’s disease [PD]…
  • 2019 International Congress

    Serum uric acid levels and cognitive function in Parkinson’s disease

    J. Difrancisco-Donoghue, W. Werner, B. Krishnamachari, K. Arabian, E. Thomas, D. Granger, R. Gallagher (Irvine, CA, USA)

    Objective: To compare serum uric acid (sUA) levels in Parkinson’s disease (PD) subjects to cognitive function. Background: Reduced sUA levels have been reported in individuals…
  • 2019 International Congress

    THE EXPRESSION OF INOS IN MOUSE EXPERIMENTAL MODEL POINTS TO INFLAMMATORY CONDITIONS ASSOCIATED WITH PARKINSON’S DISEASE

    N. Djebli (Mostaganem, Algeria)

    Objective: The objective of conducting this study was to evaluate the expression of iNOS in mouse experimental model of PD. Background: Parkinson’s Disease (PD) is…
  • 2019 International Congress

    Parkinson’s disease and melanoma: a serie of 33 patients

    J. Doridam, M. Nader, A. Melin, MF. Avril, E. Maubec, B. Degos (Paris, France)

    Objective: The objective of our work was to characterize the clinical features of patients with malignant melanoma (MM) associated with Parkinson’s disease (PD) and to…
  • « Previous Page
  • 1
  • …
  • 1276
  • 1277
  • 1278
  • 1279
  • 1280
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley